Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23596 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.22196 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.22512 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.20324 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.20822 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.27713 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.23756 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.21146 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.21089 | 9 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.21098 | 9 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.20723 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.20269 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.2189 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.21776 | 9 |